FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:1315-1316 May 5, 1994 Number 18 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Nightingale, S. D. PubMed Citation

To the Editor: Nightingale et al. (Sept. 16 issue)¹ reported no cases of uveitis among 292 patients taking 300 mg of rifabutin per day as prophylaxis against Mycobacterium avium complex infection, and there was no mention of uveitis in the guidelines on treatment and prophylaxis for M. avium complex disease (Sept. 16 issue)². However, Shafran and colleagues (Feb. 10 issue)³ reported the development of uveitis in 39 percent of 59 patients treated for M. avium complex bacteremia with 600 mg of rifabutin daily (along with clarithromycin and ethambutol). We report a case of bilateral uveitis in a patient who . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Vaudaux, J. D., Guex-Crosier, Y. (2002). Rifabutin-induced cystoid macular oedema. J Antimicrob Chemother 49: 421-422 [Abstract] [Full Text]